QURE
QURE
NASDAQ · Biotechnology

Uniqure Nv

$43.63
+1.44 (+3.41%)
As of Aug 8, 1:39 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 18 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target -59.9% upside
Low Target $11.65
Average Target $17.51
High Target $27.07
Current Price $43.63
Current
$43.63
Target
$17.51
$11.65 $17.51 avg $27.07
Scenario Analysis
Bear Case
$11.65
-73.3%
Low target
Base Case
$17.51
-59.9%
Avg target
Bull Case
$27.07
+-38.0%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$71.50
-39.0% from high
52-Week Low
$8.73
+399.8% from low
Target vs 52W High
$17.51
-75.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%